tiprankstipranks
Trending News
More News >
Advertisement

FSGS - ETF AI Analysis

Compare

Top Page

FSGS

Small Cap US Equity Select ETF (FSGS)

Rating:74Outperform
Price Target:
The Small Cap US Equity Select ETF (FSGS) demonstrates solid overall quality, driven by strong contributions from holdings like Catalyst Pharma (CPRX), which benefits from raised revenue guidance, robust financial health, and strategic initiatives. Harmony Biosciences (HRMY) also adds strength with its attractive valuation and bullish momentum. However, weaker holdings such as Mercury General (MCY), which lacks earnings call insights and faces overbought signals, may slightly temper the ETF's rating. The fund's diverse holdings mitigate risks, though concentration in small-cap stocks could introduce volatility.
Positive Factors
Sector Diversification
The ETF is spread across multiple sectors, including Technology, Financials, and Industrials, reducing reliance on any single industry.
Small Cap Growth Potential
The focus on small-cap U.S. companies offers investors exposure to businesses with high growth potential.
Healthy Year-to-Date Performance
The fund has delivered positive year-to-date returns, indicating strong overall performance in 2023.
Negative Factors
Underperforming Top Holdings
Several of the largest positions, such as Dynatrace and BlackLine, have shown weak year-to-date performance, dragging on the fund.
High Geographic Concentration
With nearly all assets invested in U.S. companies, the ETF lacks global diversification, increasing exposure to domestic market risks.
Above-Average Expense Ratio
The fund charges a relatively high expense ratio compared to similar ETFs, which can reduce net returns for investors.

FSGS vs. SPDR S&P 500 ETF (SPY)

FSGS Summary

The Small Cap US Equity Select ETF (Ticker: FSGS) focuses on small-cap companies in the U.S. extended market, which are known for their growth potential and innovation. It includes businesses across various sectors like technology, financials, and healthcare, with notable holdings such as Dynatrace and DocuSign. This ETF is ideal for investors seeking diversification and exposure to smaller, agile companies that may offer high-growth opportunities. However, new investors should be aware that small-cap stocks can be more volatile than larger companies, meaning their value can rise or fall quickly depending on market conditions.
How much will it cost me?The Small Cap US Equity Select ETF (Ticker: FSGS) has an expense ratio of 0.6%, which means you’ll pay $6 per year for every $1,000 invested. This is higher than average because the ETF is actively managed, focusing on small-cap companies with growth potential, which requires more research and management effort.
What would affect this ETF?The Small Cap US Equity Select ETF (FSGS) could benefit from economic growth and innovation in the U.S., particularly in technology and financial sectors, which are its largest exposures. However, it may face challenges from rising interest rates or economic slowdowns, which can negatively impact small-cap companies and growth-focused investments. Regulatory changes or sector-specific disruptions could also influence the performance of its top holdings.

FSGS Top 10 Holdings

The Small Cap US Equity Select ETF (FSGS) leans heavily into growth-oriented sectors like financials, technology, and industrials, showcasing its focus on agile, innovative companies. Woodward and Progyny are rising stars, with strong financial performance and strategic initiatives driving their momentum. Meanwhile, Lantheus and Cactus are holding the fund back, with mixed signals and revenue challenges weighing on their outlook. The ETF’s U.S.-centric portfolio reflects a clear commitment to domestic opportunities, offering investors a chance to ride the wave of small-cap growth while navigating the ups and downs of individual stock performance.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Harmony Biosciences Holdings1.46%$452.11K$2.22B11.49%
81
Outperform
Flowserve1.39%$431.72K$9.06B22.93%
79
Outperform
Progyny1.32%$409.68K$2.20B52.66%
79
Outperform
Woodward1.25%$386.42K$18.79B83.26%
79
Outperform
Cactus1.24%$385.98K$3.67B-19.66%
77
Outperform
New York Times1.24%$383.42K$11.53B31.90%
79
Outperform
Lantheus1.19%$368.44K$4.42B-27.54%
73
Outperform
Catalyst Pharma1.17%$363.89K$3.01B13.41%
83
Outperform
Exelixis1.17%$361.78K$12.47B36.76%
78
Outperform
Mercury General1.17%$361.61K$5.24B40.26%
69
Neutral

FSGS Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
30.63
Positive
100DMA
30.92
Positive
200DMA
29.78
Positive
Market Momentum
MACD
0.14
Negative
RSI
55.99
Neutral
STOCH
68.13
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FSGS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 30.84, equal to the 50-day MA of 30.63, and equal to the 200-day MA of 29.78, indicating a bullish trend. The MACD of 0.14 indicates Negative momentum. The RSI at 55.99 is Neutral, neither overbought nor oversold. The STOCH value of 68.13 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FSGS.

FSGS Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$31.05M0.60%
$68.61M0.69%
$56.33M0.60%
$38.85M0.38%
$34.72M0.19%
$34.14M0.50%
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FSGS
Small Cap US Equity Select ETF
31.05
1.28
4.30%
OASC
OneAscent Small Cap Core ETF
FSCS
First Trust Smid Capital Strength Etf
ASCE
Allspring SMID Core ETF
NIXT
Research Affiliates Deletions ETF
TMFX
Motley Fool Next Index ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement